Vaccines


What Is A Vaccine?

Vaccines can be prophylactic (e.g. to prevent or reduce the impact of a future infection by a pathogen), or therapeutic (e.g. cancer vaccines are being investigated). Vaccines exist in many different forms which may contain live, attenuated virus, or an inactivated micro-organism, or some unique molecular component of the organism that causes illnesses. Vaccines can generally be classified as Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Vector Vaccine, Conjugate Vaccine, DNA and RNA Vaccine and more.


The Type of Vaccines

Vaccines can be prophylactic (e.g. to prevent or reduce the impact of a future infection by a pathogen), or therapeutic (e.g. cancer vaccines are being investigated). Vaccines exist in many different forms which may contain live, attenuated virus, or an inactivated micro-organism, or some unique molecular component of the organism that causes illnesses. Vaccines can generally be classified as Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Vector Vaccine, Conjugate Vaccine, DNA and RNA Vaccine and more.

 

PRODUCT NAME LABEL COMPOSITION PACK THERAPEUTIC USE
DTwP – rHeb B – Hib (liquid) Pentavalent : Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA) and Haemophilus Type b conjugate Vaccine (Adsorbed) WHO Prequalified Each dose of 0.5 ml contains Diphtheria Formol Toxoid : >30 IU (>20 Lf to < 30 Lf) Tetanus Formol Toxoid : > 60 IU (> 5 Lf to < 25 Lf) Bordetella Pertussis (Whole cell, Killed > 4 IU r-HBsAg : (Recombinant HBs antigen produced in Pichia Pastoris) Purified capsular polysaccharide of Hib (PRP) covalently linked to 20 to 36.7 µg of tetanus formol toxoid : 11 µg Al+++ (as AIPO4) : < 1.25 mg Preservative : Thiomersal : 0.5 ml vial 5 ml vial Immunization against Diphtheria, Tetanus, Pertussis and Hepatitis B and Haemophilus Influenza type b
DTwP –rHep B + Hib (lyophilized) Pentavalent : Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus Type b Conjugate Vaccine (Adsorbed) WHO Prequalified Each reconstituted dose of 0.5 ml contains : Diphtheria Toxoid : > 30 IU Tetanus Toxoid : > 60 IU B.Pertussis (Whole cell) : > 4 IU r-HBs Ag : 10 µg Purified Capsular Polysaccharide (PRP): 10 µg Tetanus Toxoid (Carrier protein) 19 to 33 µg Al+++ (as AIPO4) : < 1.25 mg Preservative : Thiomersal BP 0.01% 0.5 ml vial 5 ml vial Immunization against Diphtheria, Tetanus, Pertussis and Hepatitis B and Haemophillus Influenza type b
TT Adsorbed Tetanus Vaccine WHO Prequalified Each dose of 0.5 ml contains Tetanus Toxoid :  5 Lf to ≤ 25 Lf Aluminium Phosphate :  1.5 mg Thiomersal : 0.01 % w/v 0.5 ml vial 5 ml vial 10 ml vial Active Immunization for Tetanus
JE Japanese Encephalitis Vaccine (Human) (Purified Inactivated Vaccine – Adsorbed) WHO Prequalified Each 0.5 ml contains Purified Inactivated Japanese Encephalitis Virus Strain (SA14-14-2): 6 µg Aluminium as Aluminium Hydroxide : 0.1% w/v Phosphate Buffer Saline q.s 0.5 ml vial 0.25 ml vial Immunization against Japanese Encephalitis
DTwP Adsorbed Diphtheria, Tetanus and Pertussis (Whole Cell) Vaccine 0.5 ml dose contains Diphtheria Toxoid :  20 Lf to ≤ 30Lf Tetanus Toxoid :  5 Lf to ≤25 Lf B.Pertussis (Whole cell) :  4 IU Aluminium phosphate :  1.5 mg Thiomersal : 0.01 % w/v 0.5 ml vial 5 ml vial 10 ml vial Immunization for Diphtheria, Pertussis and Tetanus
DT Adsorbed Diphtheria and Tetanus Vaccine Each dose of 0.5 ml contains Diphtheria Toxoid :  20 Lf to ≤ 30 Lf Tetanus Toxoid :  5 Lf to ≤ 25 Lf Aluminium Phosphate :  1.5 mg Thiomersal : 0.01 % w/v 0.5 ml vial 5 ml vial 10 ml vial Immunization for Diphtheria and Tetanus
Td Adsorbed Diphtheria and Tetanus Vaccine for Adults and Adolescents Each dose of 0.5 ml contains : Diphtheria Toxoid < 2 Lf Tetanus Toxoid >20 IU Adsorbed on Aluminium Phosphate (Al PO4) > 1.5 mg Preservative : Thiomersal 0.01% w/v 0.5 ml vial 5 ml vial Immunization against Tetanus and Diphtheria for Adults and Adolescents

© Copyright 2018 Phaax | All Rights Reserved